Medicinal Psychedelics Conference

The Medicinal Psychedelics Conference will take place on July 25, 2024, at the Crown Promenade in Melbourne. This event serves as a platform for networking and discussion surrounding the therapeutic potential of psychedelic compounds for medical and psychological treatments. After Australia became the first country to legalize the use of psychedelics for certain mental health conditions, this conference gathers leading experts, psychiatrists, researchers, clinicians, policymakers, and industry pioneers to explore the latest developments in the field.

Attendees will have the opportunity to connect with important partners, gain practical insights into the evolving sector, and engage in discussions with professionals on the frontlines. Key topics of discussion include the progress made since MDMA and Psilocybin were moved to Schedule 8 medicines in Australia, the effectiveness of psychedelics in treating conditions such as depression, anxiety, PTSD, and addiction, ethical and legal considerations in psychedelic therapy, and the future of mental healthcare.

The conference features a lineup of speakers, including Emily Rigby, Interim Chair of the Australian Medicinal Cannabis Association, Dr. Suresh Muthukumaraswamy, Associate Professor at The University of Auckland, and Prof. Jerome Sarris, Co-CEO of Psychae Therapeutics. The agenda includes keynote speeches, panel discussions, and case studies, covering a range of relevant topics. Registration for the event is currently open, with early bird rates available until June 7, 2024.